{
  "id": 2862600,
  "title": "Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?",
  "url": "https://urgent.news/2026/08/23/better-dividend-king-to-buy-right-now-abbott-labs-or-johnson-johnson-2862600",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-23T20:20:00.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/healthcare/articles/better-dividend-king-buy-now-202000465.html"
  },
  "original_language": "en",
  "account": "Two notable healthcare companies, Abbott Laboratories and Johnson & Johnson, are both part of the Dividend Kings club, having raised their dividends for over 50 years consecutively. However, Abbott's recent performance has been lagging behind Johnson & Johnson's growth. Abbott faced challenges in its diagnostics and nutrition segments, legal and regulatory issues, and lawsuits affecting its baby formula product. Meanwhile, Johnson & Johnson navigated patent exclusivity loss, government negotiations, and introduced new products like Icotyde and Ottava, demonstrating promising growth potential. With a stronger revenue and earnings track record, Johnson & Johnson's dividend history is also longer, with 64 straight years of increases compared to Abbott's 54. Despite Abbott's acquisition of Exact Sciences, offering potential growth, Johnson & Johnson's overall performance and dividend growth make it the more attractive investment at the moment.",
  "summary": null,
  "key_points": [
    "Abbott Laboratories faces challenges in diagnostics, nutrition, and baby formula lawsuits",
    "Johnson & Johnson has 64 years of consecutive dividend increases vs Abbott's 54",
    "Johnson & Johnson shows stronger revenue, earnings, and growth potential"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?",
        "url": "https://urgent.news/2026/08/23/better-dividend-king-to-buy-right-now-abbott-labs-or-johnson-johnson",
        "published": "2026-08-23T20:00:00.000Z"
      },
      {
        "outlet": "Nasdaq Markets",
        "title": "Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?",
        "url": "https://urgent.news/2026/08/23/better-dividend-king-to-buy-right-now-abbott-labs-or-johnson-johnson-2868507",
        "published": "2026-08-23T20:20:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}